abstract |
The present invention relates to; a therapeutic agent for chronic kidney disease, which comprises a substance capable of reducing the enzymatic activity of NNMT or a substance capable of inhibiting the expression of a gene for NNMT; and a method for screening for a therapeutic agent for chronic kidney disease, which targets an enzyme NNMT or a gene for NNMT. |